Plyushkin I have followed and chronicled the ups and downs of ACADIA Pharmaceuticals (NASDAQ:ACAD) since 07/2017's "Acadia: Order For Central Nervous Systems In Need". My most recent Acadia article was "Acadia Pharmaceuticals: Nuplazid's (Pimavanserin) Last Hurrah" ("Hurrah"). As for Soleno Therapeutics (NASDAQ:SLNO) this is my very first analysis of it. The indication that ties these two together in this article is their respective late stage trials in treatment of Prader-Willi Syndrome [PWS]. PWS is a dev ...